Drreddys Laboratories | RDY - Equity Capital And Reserves


Drreddys Laboratories reported INR4.14B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
ANI Pharmaceuticals USD 505.82M 69.06M Sep/2025
Aurora Cannabis CAD 567.1M 21.58M Sep/2025
Bayer EUR 29.7B 799M Sep/2025
Canopy Growth CAD 736.01M 247.04M Sep/2025
Cipla INR 329.19B 16.3B Sep/2025
Corcept Therapeutics USD 631.9M 3.89M Sep/2025
Drreddys Laboratories INR 4.14B 107.72M Dec/2025
GlaxoSmithKline GBP 16.15B 1.79B Sep/2025
Hikma Pharmaceutical USD 2.55B 230M Jun/2025
Lonza CHF 9.33B 23M Dec/2024
Novartis USD 44.75B 2.7B Sep/2025
Pacira USD 727.21M 30.55M Sep/2025
Prestige Brands USD 1.82B 30.51M Sep/2025
Richter Gedeon HUF 1.33T 31.97B Sep/2025
Sun Pharmaceuticals INR 778.2B 56.02B Sep/2025
Supernus Pharmaceuticals USD 1.05B 14.23M Sep/2025
Teva Pharmaceutical Industries USD 7.91B 664M Dec/2025